EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway

Marta Del Pozo-Medina, Polina Soluyanova, Eugenia Pareja, Marta Moreno-Torres iD, Ramiro Jover

Archives of Toxicology · 2026-12 · 100 (12) · 5541-5556

DOI: 10.1007/s00204-026-04513-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 22.07.2026. Verfasst von Marta Del Pozo-Medina und 4 weiteren Autor:innen. Beteiligte Einrichtung: CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain. Hauptthemen laut MEDLINE: Hepatocytes, Receptors, Aryl Hydrocarbon, Insulin-Like Growth Factor Binding Protein 1, Fatty Liver. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Valencia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction–associated steatotic liver disease (MASLD) represents a growing global health concern; however, its multiple pathogenic mechanisms remain incompletely understood. The role of the aryl hydrocarbon receptor (AHR) in MASLD is controversial, as it has been described as either pro- or anti-steatotic depending on the experimental context. Through whole-genome expression profiling and RT-qPCR analysis of human liver biopsies from two independent MASLD patient cohorts, we demonstrate that AHR expression and its canonical activity—assessed by CYP1A1 mRNA levels—are inversely correlated with hepatic steatosis. The role of AHR was further investigated in cultured human Upcyte® hepatocytes from different donors treated with a 2:1 oleate:palmitate mixture (0.6 mM) to induce steatosis, in combination with the exogenous AHR agonist β-naphthoflavone (BN, 25 µM) or the endogenous agonist 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE, 25 µM). Activation of AHR resulted in a statistically significant reduction of intracellular lipid levels, as determined by triglyceride quantification and AdipoRed staining. Microarray analysis of AHR-activated human hepatocytes identified IGFBP1 as a robustly induced target gene. Consistently, IGFBP1 expression was diminished in the livers of both MASLD cohorts and positively correlated with AHR expression levels. Furthermore, treatment of human hepatocytes with recombinant IGFBP1, alone or in combination with IGF1, reduced lipid accumulation, supporting IGFBP1 as a potential downstream effector within the anti-steatotic AHR pathway. Collectively, these findings support a role for AHR and its target IGFBP1, as key negative regulators of hepatic lipid accumulation in human hepatocytes and suggest that activation of this pathway may be taken into account in the therapeutic approaches for MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesReceptors, Aryl HydrocarbonInsulin-Like Growth Factor Binding Protein 1Fatty LiverBasic Helix-Loop-Helix ProteinsHumansDown-RegulationCytochrome P-450 CYP1A1beta-NaphthoflavoneCells, CulturedMaleSignal TransductionIndolesThiazolesLiverOleic AcidFemaleGene Expression ProfilingMiddle Aged

Stichwörter der Autor:innen

AHRIGFBP1Lipid accumulationMASLDSteatosis

Substanzen

Receptors, Aryl HydrocarbonInsulin-Like Growth Factor Binding Protein 1IGFBP1 protein, humanCytochrome P-450 CYP1A1beta-NaphthoflavoneCYP1A1 protein, human2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl esterAHR protein, humanIndolesBasic Helix-Loop-Helix Proteins

Autor:innen und Institutionen

  • CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
  • Experimental Hepatology Joint Research Unit. Health Research Institute La Fe, Valencia, Spain.
  • Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario Dr. Peset, Valencia, Spain.
  • CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain. marta.moreno.torres@uv.es.
  • Experimental Hepatology Joint Research Unit. Health Research Institute La Fe, Valencia, Spain. marta.moreno.torres@uv.es.
  • Biochemistry and Molecular Biology Department, Universitat de València, Valencia, Spain. marta.moreno.torres@uv.es.

ORCID-Profile: Marta Moreno-Torres

Förderung

  • Universitat de Valencia

Zitieren

APA

Del Pozo-Medina, M., Soluyanova, P., Pareja, E., Moreno-Torres, M., & Jover, R. (2026). The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway. Archives of Toxicology, 100(12), 5541-5556. https://doi.org/10.1007/s00204-026-04513-w

Vancouver

Del Pozo-Medina M, Soluyanova P, Pareja E, Moreno-Torres M, Jover R. The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway. Archives of Toxicology. 2026;100(12):5541-5556. doi:10.1007/s00204-026-04513-w

BibTeX
@article{DelPozoMedina2026,
  author = {Del Pozo-Medina, Marta and Soluyanova, Polina and Pareja, Eugenia and Moreno-Torres, Marta and Jover, Ramiro},
  title = {The aryl hydrocarbon receptor is downregulated in MASLD while its activation attenuates steatosis in human hepatocytes through an IGFBP1-associated pathway},
  journal = {Archives of Toxicology},
  year = {2026},
  volume = {100},
  number = {12},
  pages = {5541--5556},
  doi = {10.1007/s00204-026-04513-w}
}
Kostenlos starten →